Now showing items 1-2 of 2

    • Molecular characterization of chordoma xenografts generated from a novel primary chordoma cell source and two chordoma cell lines. 

      Alcorta, DA; Bagley, CA; Bell, RD; Chen, J; Gabr, Mostafa A; Gilchrist, CL; Jing, L; ... (11 authors) (J Neurosurg Spine, 2014-09)
      OBJECT: Chordoma cells can generate solid-like tumors in xenograft models that express some molecular characteristics of the parent tumor, including positivity for brachyury and cytokeratins. However, there is a dearth of ...
    • X-Ray Psoralen Activated Cancer Therapy (X-PACT). 

      Adamson, Justus D; Alcorta, DA; Beyer, WF; Dewhirst, Mark Wesley; Dodd, RD; Fathi, Z; Fecci, Peter Edward; ... (20 authors) (PLoS One, 2016)
      This work investigates X-PACT (X-ray Psoralen Activated Cancer Therapy): a new approach for the treatment of solid cancer. X-PACT utilizes psoralen, a potent anti-cancer therapeutic with current application to proliferative ...